| Target Price | $205.94 |
| Price | $143.23 |
| Potential | 43.78% |
| Number of Estimates | 13 |
| 13 Analysts have issued a price target CDW Corp. 2026 . The average CDW Corp. target price is $205.94. This is 43.78% higher than the current stock price. The highest price target is $246.75 72.28% , the lowest is $177.76 24.11% . | |
| A rating was issued by 17 analysts: 11 Analysts recommend CDW Corp. to buy, 6 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the CDW Corp. stock has an average upside potential 2026 of 43.78% . Most analysts recommend the CDW Corp. stock at Purchase. |
14 Analysts have issued a sales forecast CDW Corp. 2025 . The average CDW Corp. sales estimate is $22.4b . This is 1.47% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $23.8b 7.61% , the lowest is $21.4b 2.97% .
This results in the following potential growth metrics:
| 2024 | $21.0b | 1.77% |
|---|---|---|
| 2025 | $22.4b | 6.79% |
| 2026 | $23.1b | 2.89% |
| 2027 | $24.1b | 4.31% |
10 Analysts have issued an CDW Corp. EBITDA forecast 2025. The average CDW Corp. EBITDA estimate is $2.1b . This is 10.89% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $2.6b 33.39% , the lowest is $2.0b 1.48% .
This results in the following potential growth metrics and future EBITDA Margins:
| 2024 | $1.9b | 1.28% |
|---|---|---|
| 2025 | $2.1b | 10.77% |
| 2026 | $2.2b | 5.30% |
| 2027 | $2.4b | 4.63% |
| 2024 | 9.17% | 0.49% |
|---|---|---|
| 2025 | 9.52% | 3.76% |
| 2026 | 9.74% | 2.31% |
| 2027 | 9.77% | 0.31% |
13 CDW Corp. Analysts have issued a net profit forecast 2025. The average CDW Corp. net profit estimate is $1.3b . This is 23.40% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $1.4b 29.62% , the lowest is $1.3b 19.02% .
This results in the following potential growth metrics and future Net Margins:
| 2024 | $1.1b | 2.40% |
|---|---|---|
| 2025 | $1.3b | 20.36% |
| 2026 | $1.4b | 6.08% |
| 2027 | $1.5b | 8.44% |
| 2024 | 5.13% | 0.65% |
|---|---|---|
| 2025 | 5.79% | 12.81% |
| 2026 | 5.96% | 2.94% |
| 2027 | 6.20% | 4.03% |
13 Analysts have issued a CDW Corp. forecast for earnings per share. The average CDW Corp. EPS is $9.96 . This is 24.97% higher than earnings per share in the financial year 2024. The highest EPS forecast is $10.46 31.24% , the lowest is $9.60 20.45% .
This results in the following potential growth metrics and future valuations:
| 2024 | $7.97 | 1.60% |
|---|---|---|
| 2025 | $9.96 | 24.97% |
| 2026 | $10.56 | 6.02% |
| 2027 | $11.45 | 8.43% |
| Current | 17.81 | 18.21% |
|---|---|---|
| 2025 | 14.25 | 19.97% |
| 2026 | 13.44 | 5.68% |
| 2027 | 12.39 | 7.81% |
Based on analysts' sales estimates for 2025, the CDW Corp. stock is valued at an EV/Sales of 1.05 and an P/S ratio of 0.82 .
This results in the following potential growth metrics and future valuations:
| Current | 1.07 | 22.46% |
|---|---|---|
| 2025 | 1.05 | 1.42% |
| 2026 | 1.03 | 2.82% |
| 2027 | 0.98 | 4.13% |
| Current | 0.84 | 26.97% |
|---|---|---|
| 2025 | 0.82 | 1.45% |
| 2026 | 0.80 | 2.82% |
| 2027 | 0.77 | 4.13% |
| Analyst | Rating | Action | Date |
|---|---|---|---|
| UBS |
Buy
➜
Buy
|
Unchanged | Nov 05 2025 |
| Barclays |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Nov 05 2025 |
| Evercore ISI Group |
Outperform
➜
Outperform
|
Unchanged | Oct 20 2025 |
| Barclays |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Aug 07 2025 |
| UBS |
Buy
➜
Buy
|
Unchanged | Aug 07 2025 |
| JP Morgan |
Neutral
➜
Neutral
|
Unchanged | Jul 17 2025 |
| Citigroup |
Neutral
➜
Neutral
|
Unchanged | Jul 11 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
UBS:
Buy
➜
Buy
|
Nov 05 2025 |
|
Unchanged
Barclays:
Equal-Weight
➜
Equal-Weight
|
Nov 05 2025 |
|
Unchanged
Evercore ISI Group:
Outperform
➜
Outperform
|
Oct 20 2025 |
|
Unchanged
Barclays:
Equal-Weight
➜
Equal-Weight
|
Aug 07 2025 |
|
Unchanged
UBS:
Buy
➜
Buy
|
Aug 07 2025 |
|
Unchanged
JP Morgan:
Neutral
➜
Neutral
|
Jul 17 2025 |
|
Unchanged
Citigroup:
Neutral
➜
Neutral
|
Jul 11 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


